Company: INKT
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0001193125-25-009595
Chunk: 1

Company: MiNK Therapeutics, Inc.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 5.07
Chunk 1
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

The Special Meeting was held on January 17, 2025. Only stockholders of record as of December 16, 2024 (the “ Record Date”) were entitled to vote at the Special Meeting. As of the Record Date, there were 39,630,402 shares outstanding and entitled to vote at the Special Meeting, of which 27,582,512 shares were present or represented by proxy, constituting a quorum on all matters voted upon. The final voting results of the Special Meeting are as follows:

Proposal 1: Approval of the Certificate of Amendment to the Certificate of Incorporation to effect a reverse stock split of the Company’s issued and outstanding common stock at a ratio of1-for-10.

In accordance with the results below, Proposal 1 was approved.

         For        Against      Abstain      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────
  26,500,274      1,026,255       56,013      —